Aspiriant - San Francisco, California 94105

Aspiriant is categorized under Financial Services in San Francisco, CA .

Business Name: Aspiriant
Contact Person: Robert Francis, Chief Executive Officer
Address: 101 2nd St # 1400, San Francisco, California 94105
Phone Number: (415) 371-1679
Website Address: aspiriant.com
Annual Revenue (USD): $20.000.000 to $49.9999.999
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Financial Services
SIC Code: 7389
NAICS Code: 5239300
Share This Business:
Related Businesses: Nestwise LLC - San Francisco, CA 94105
Avicenna Capital Management L P - San Francisco, CA 94105
Flock Inc - San Francisco, CA 94105
Monte Vista Management - San Francisco, CA 94105
Manager's Investment Group - San Francisco, CA 94105
Opencoin Inc - San Francisco, CA 94105
Fundbox - San Francisco, CA 94105
Seventy Medical Hall - San Francisco, CA 94105
Career Partners - San Francisco, CA 94105
M Foundry - San Francisco, CA 94105
Promontory Financial Group LLC - San Francisco, CA 94105
Innovest Strategic Value Advisors - San Francisco, CA 94105
Akahi Capital Management LLC - San Francisco, CA 94105
Black Rock Inc - San Francisco, CA 94105
Legend Merchant Group - San Francisco, CA 94105
Ipfs Corporation - San Francisco, CA 94105
Global Privacy Alliance - San Francisco, CA 94105
Zubair Zubi - San Francisco, CA 94105

The company Aspiriant provides B2B services in the form of Financial Services from its branch in California. 1 to 4 employees work for Aspiriant, and the business now earns $20.000.000 to $49.9999.999 per annum.

Aspiriant was launched in 0 and is classified under SIC code and category 7389 , and NAICS number and grouping 5239300 . To contact Aspiriant, please call Robert Francis, Chief Executive Officer with the phone number (415) 371-1679 or visit its branch at 101 2nd St # 1400 in San Francisco, California 94105.

The location of the branch can also be found using the coordinates 37.788025,-122.399777. Read more details about this business on the webpage aspiriant.com or follow the company’s social media accounts, on Twitter and on Facebook.